by Eric Christianson | Dec 31, 2025 | Psychiatry and Addiction Medication and Disease State Clinical Pearls
Pimavanserin is a unique antipsychotic with a very specific niche in clinical practice. It is most commonly used for Parkinson’s disease psychosis, and its pharmacology, benefits, and risks are frequently tested and clinically misunderstood. In this blog post,...
by Eric Christianson | Dec 10, 2025 | Psychiatry and Addiction Medicine Case Studies
I recently came across a case scenario of drug induced akathisia. It is important to remember that aripiprazole is one of the most common causes of this adverse effect. Here’s the case – LY is a 72-year-old man with a 10-year history of Parkinson’s disease...
by Eric Christianson | Apr 2, 2025 | Neurology, Pain, and Musculoskeletal Medication and Disease State Clinical Pearls
Sinemet, a key medication for managing Parkinson’s disease, combines carbidopa and levodopa to improve motor symptoms such as tremors, stiffness, and slow movement. However, Sinemet is known for its potential drug interactions, which can affect its efficacy and lead...
by Eric Christianson | Oct 30, 2024 | Neurology, Pain, and Musculoskeletal Medication and Disease State Clinical Pearls
Dementia with Lewy Bodies (DLB) is a type of dementia grouped under the term “Lewy Body Dementia” along with Parkinson Disease with Dementia (PDD)1. The main symptoms of DLB are parkinsonism, REM sleep disorder, visual hallucinations, and changes in cognition2. There...
by Eric Christianson | Feb 21, 2024 | Neurology, Pain, and Musculoskeletal Medication and Disease State Clinical Pearls
I have been caught in situations with caregivers and patients numerous times regarding Parkinson’s medication management. Patients can be VERY particular about getting their Parkinson’s medication on time. This is understandable if you acknowledge what...
